TREA

79279617 - LIGHTBIO

Follow

Information

  • Trademark
  • 79279617
  • Serial Number
    79279617
  • Registration Number
    6375045
  • Filing Date
    August 28, 2019
    5 years ago
  • Registration Date
    June 08, 2021
    3 years ago
  • Transaction Date
    October 24, 2021
    2 years ago
  • Status Date
    June 08, 2021
    3 years ago
  • Published for Opposition Date
    March 23, 2021
    3 years ago
  • Location Date
    June 08, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LEVINE, HOWARD B
  • Attorney Docket Number
    60895-527881
    Attorney Name
    Rebecca Liebowitz
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
LIGHTBIO
Case File Statements
  • GS0011: Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in scientific research in the field of agri-biotechnology and nanotechnology; nucleic acids comprising natural and unnatural nucleotides for use in laboratory nanotechnology applications, namely, data storage, data retrieval and computing; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in laboratory nanotechnology applications, namely, data storage, data retrieval and computing; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in laboratory nanotechnology applications, namely, data storage, data retrieval and computing; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labelling, imaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds; Nucleic acids comprising natural and unnatural nucleotides for laboratory use; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for laboratory use; composites of nucleic acids or nucleic acid analogues with organic and NAC inorganic chemicals for laboratory use; all the aforesaid goods for use in laboratory nanotechnology applications, namely, data storage, data retrieval and computing
  • GS0051: Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labeling, imaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds
  • GS0091: Scientific apparatus and instruments, namely, apparatus for amplifying DNA, namely, reactors and bioreactors; apparatus for manufacturing DNA, namely, reactors and bioreactors; apparatus for processing DNA, namely, reactors and bioreactors; electronic components, namely, nucleic acid analogues in the nature of electric and power wires, semi-conductors, transistors, rectifiers, diodes, light emitting diodes and energy storage systems in the nature of devices for energy storage, namely, batteries, fuel cells configured for energy storage, and electrochemical devices configured for energy storage, namely, electrolysers; electric and power wires comprised of nucleic acid composites (NACs) semi-conductors, transistors, rectifiers, diodes, light emitting diodes and energy storage systems in the nature of devices for energy storage, namely, batteries, fuel cells configured for energy storage, and electrochemical devices configured for energy storage, namely, electrolysers, each comprised of nucleic acid composites (NACs); labeling, imaging and sensing apparatus comprising of nucleic acid composites (NACs) for laboratory and research use; smart materials in the nature of DNA chips, DNA microarrays, comprised of nucleic acid composites; two-dimensional and three-dimensional nucleic acid composites (NACs) in the nature of DNA chips, DNA microarrays for creating nanostructures and scaffolds for use in electronic components and materials, namely, electrical conductors; parts and fittings for all the aforesaid technology and parts and fittings for all the aforesaid goods, namely, electrical cables, display screens, transmitters
  • GS0401: Chemical treatment of DNA to form DNA extracts; custom manufacture of therapeutic DNA by the manipulation of DNA into DNA extracts or cassettes
  • GS0421: Scientific and technological services and research and design relating thereto, namely, chemical and biological analysis and research services; DNA analysis services for scientific research purposes; scientific research and development into the creation of DNA extracts; scientific research, analysis, design and development relating to DNA based drugs and therapies; scientific research and development in the fields of gene therapy, genetic diagnostics, agri-biotechnology and nanotechnology, all in the field of gene therapy; consultancy relating to the aforesaid services
  • PM0001: LIGHT BIO
Case File Event Statements
  • 10/24/2021 - 2 years ago
    35 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 9/28/2021 - 2 years ago
    34 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/28/2021 - 2 years ago
    33 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/8/2021 - 3 years ago
    32 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/8/2021 - 3 years ago
    31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/23/2021 - 3 years ago
    30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/23/2021 - 3 years ago
    29 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/21/2021 - 3 years ago
    28 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 3/3/2021 - 3 years ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/3/2021 - 3 years ago
    26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 3/3/2021 - 3 years ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/16/2021 - 3 years ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/16/2021 - 3 years ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/16/2021 - 3 years ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/16/2021 - 3 years ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/16/2021 - 3 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/11/2021 - 3 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/11/2021 - 3 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/11/2021 - 3 years ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 1/7/2021 - 3 years ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 1/7/2021 - 3 years ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 1/7/2021 - 3 years ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 12/17/2020 - 3 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/17/2020 - 3 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/15/2020 - 3 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 9/21/2020 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/10/2020 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/25/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/25/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/6/2020 - 4 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/4/2020 - 4 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/3/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/2/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/2/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/27/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR